DYNT Dynatronics Corporation: Debt to Equity

Dynatronics Corp. - graphic logo of issuer DYNT

The market valuation chart for Dynatronics Corporation (DYNT) helps analyze the debt load amid partnerships with rehabilitation centers, where distribution synergy for instruments improves therapy outcomes. The business generates revenue from supplying equipment for athletes and physicians, with the indicator standing at 0.00. The current strategic vector suggests a gradual exit from operational activities, the sale of real estate, and the return of capital to shareholders.

DYNT: Dynatronics Corp Debt to Capital 07/04/2022 - 08/04/2024
Finished products of Dynatronics

The financial stability of Dynatronics Corporation (DYNT) depends on the balance between debt and equity, which is critical when investing in high-tech rehabilitation systems equipped with control sensors. By analyzing the current total debt-to-equity ratio, an investor determines the extent of the business's dependence on creditors: a rising trend indicates an increasing debt load, while a decline reflects the strengthening of the company's financial autonomy.

Key competitors

Debt to Equity Boston Scientific Corporation|Edwards (EW) - Total Debt to Capital Coefficient|Debt to Equity ResMed Corp (RMD)|PODD: Aggregate Debt to Equity|Total Debt to Capital ZBH (Zimmer Biomet Corp)|coopercos.com (COO) - Debt to Capital|Align Technology - Total Debt to Capital|Globus Medical Inc (GMED) - Total Debt to Equity Ratio|TMDX: Total Debt to Capital|ATEC - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital enovis.com|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity ESTA (Establishment Labs Corp)|Total Debt to Capital BBNX (Beta Bionics Corp)|Total Debt to Capital Coefficient IRADIMED Inc. (IRMD)|EMBC: Total Debt to Equity Ratio|Aggregate Debt to Equity TNDM|AXGN: Total Debt to Capital|Debt to Capital SI-BONE Inc (SIBN)|OFIX (Orthofix International) - Total Debt to Capital|Debt to Equity Ratio BVS (Bioventus Global)|Total Debt to Equity Ratio KIDS (OrthoPediatrics Corp.)|TMCI (treace.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Strata Critical Medical SRTA|CARL - Total Debt to Equity Ratio|RxSight Corp - Total Debt to Capital|Debt to Capital ClearPoint Neuro, Inc.|STXS: Total Debt to Capital|Debt to Equity Ratio STIM|SGHT (Sight Sciences) - Total Debt to Capital|Orchestra BioMed Inc. (OBIO) - Total Debt to Capital Coefficient|Total Debt to Capital ANIK|Total Debt to Equity Ratio InspireMD Inc. NSPR|Total Debt to Capital ZJYL (Jin Medical)|Total Debt to Capital Vivani Medical Inc VANI|XTNT - Debt to Equity|NMTC: Debt to Equity|MODD (modular-medical.com) - Total Debt to Equity Ratio|Myomo Inc - All Debt to Shareholders' Equity Ratio|COCH (Envoy Medical, Inc.) - Total Debt to Capital|Debt to Capital vivoslife.com VVOS|Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Debt to Capital Ratio|Tenon Medical, Inc - Total Debt to Equity Ratio|Total Debt to Capital Lifeward Ltd. LFWD|Autonomix - Total Debt to Capital|Total Debt to Capital Coefficient invobioscience.com IVF|Bone Biologics Corp (BBLG) - Debt to Equity|Aggregate Debt to Equity AXNX (Axonics Inc.)|Debt to Equity Biolase, Inc.|Total Debt to Equity Ratio Paragon 28 Corp (FNA)|Total Debt to Capital INVO